Endocrine Therapy for Prostate Cancer
- 1 December 1991
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 20 (4) , 845-872
- https://doi.org/10.1016/s0889-8529(18)30247-0
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Synthetic progestins stimulate prostatic binding protein messenger RNAs in the rat ventral prostateMolecular and Cellular Endocrinology, 1990
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1988
- Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive shionogi tumor in miceJournal of Steroid Biochemistry, 1988
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Cardiovascular Complications in the Treatment of Prostatic CarcinomaBritish Journal of Urology, 1981
- The Accuracy of the Rectal Examination in the Diagnosis of Prostate CarcinomaNew England Journal of Medicine, 1980
- Action of a non-steroid anti-androgen, RU 23908, in peripheral and central tissuesJournal of Steroid Biochemistry, 1979
- Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.Journal of Clinical Investigation, 1979